Clinical trial endpoint technology and evidence generation platform
Clario operates a clinical-evidence platform serving pharma, biotech, and medical device companies with specialized endpoint solutions (cardiac, imaging, respiratory, eCOA). The tech stack is enterprise-grade (.NET, Azure, AWS, SQL Server, PostgreSQL, Oracle) with modern DevOps tooling (Git, Jira, Azure DevOps), now adopting AI coding assistants (GitHub Copilot, Tabnine) — a signal of accelerating engineering velocity. The hiring surge (35 roles in 30 days, engineering-heavy at 40% of openings) paired with active cloud migration and microservices projects suggests scaling infrastructure to handle trial volume growth.
Clario generates clinical evidence for pharmaceutical, biotech, and medical device companies through specialized endpoint technologies: cardiac safety monitoring, medical imaging analysis, electronic patient-reported outcomes (eCOA), respiratory endpoints, and precision motion assessment. Founded over 50 years ago, the company has supported clinical trials across 100+ countries and contributed to more than 60% of FDA drug approvals since 2019. Headquartered in Philadelphia with 1,001–5,000 employees, Clario operates globally with active hiring across nine countries. Core operations span study management, clinical data pipelines, site onboarding, and quality/compliance workflows, supported by enterprise cloud platforms and a growing data science function.
Clario runs .NET, C#, and Azure/AWS for cloud compute; SQL Server, PostgreSQL, and Oracle for databases; Angular for front-end; Python, Django, Flask for backend services; Salesforce for CRM; and Git/Jira/Azure DevOps for DevOps. Recently adopting GitHub Copilot and Tabnine.
Clario actively hires across nine countries: United States, Canada, United Kingdom, Germany, Belgium, Hungary, Turkey, India, and Costa Rica.
Other companies in the same industry, closest in size